HC Wainwright & Co. Maintains Buy on Nuvation Bio, Lowers Price Target to $4.5
HC Wainwright & Co. analyst Robert Burns maintains Nuvation Bio (NYSE:NUVB) with a Buy and lowers the price target from $14 to $4.5.
BMO Capital Downgrades Nuvation Bio to Market Perform, Lowers Price Target to $2.5
BMO Capital analyst Evan Seigerman downgrades Nuvation Bio (NYSE:NUVB) from Outperform to Market Perform and lowers the price target from $8 to $2.5.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 61 companies made new 52-week lows.
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers
Biophytis (NASDAQ:BPTS) stock moved upwards by 15.8% to $0.95 during Monday's after-market session. The company's market cap stands at $15.5 million.
Short Volatility Alert: Nuvation Bio Inc.
On Friday, shares of Nuvation Bio Inc. (NYSE: NUVB) experienced volatile short activity. After the activity, the stock price went up +0% to $4.04.
The overall sentiment for NUVB has been Bearish.